Literature DB >> 12915069

The rotenone model of Parkinson's disease: genes, environment and mitochondria.

J Timothy Greenamyre1, Ranjita Betarbet, Todd B Sherer.   

Abstract

Parkinson's disease (PD) is occasionally caused by single gene mutations or by single toxic exposures, but most cases of PD are probably caused by some combination of genetic susceptibility and environmental exposure. Using rotenone as a prototype for an environmental toxicant, we argue here that genetic and environmental causes of PD converge on common pathogenic mechanisms. If so, protective strategies devised for one type of PD may be broadly useful for other forms of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915069     DOI: 10.1016/s1353-8020(03)00023-3

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  74 in total

1.  Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin.

Authors:  Camila G Moreira; Janaína K Barbiero; Deborah Ariza; Patrícia A Dombrowski; Pamela Sabioni; Mariza Bortolanza; Claudio Da Cunha; Maria A B F Vital; Marcelo M S Lima
Journal:  Neurotox Res       Date:  2011-09-28       Impact factor: 3.911

Review 2.  Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease.

Authors:  Irmgard Paris; Sergio Cardenas; Jorge Lozano; Carolina Perez-Pastene; Rebecca Graumann; Alejandra Riveros; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

Review 3.  The mitochondrial permeability transition in neurologic disease.

Authors:  M D Norenberg; K V Rama Rao
Journal:  Neurochem Int       Date:  2007-03-04       Impact factor: 3.921

4.  Rotenone induces cell death of cholinergic neurons in an organotypic co-culture brain slice model.

Authors:  Celine Ullrich; Christian Humpel
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

5.  Nigral degeneration with inclusion body formation and behavioral changes in rats after proteasomal inhibition.

Authors:  Chaoshi Niu; Jiaming Mei; Qi Pan; Xianming Fu
Journal:  Stereotact Funct Neurosurg       Date:  2009-02-18       Impact factor: 1.875

6.  Perfluorooctane Sulfonate (PFOS) Produces Dopaminergic Neuropathology in Caenorhabditis elegans.

Authors:  Shreesh Raj Sammi; Rachel M Foguth; Claudia Sofía Nieves; Chloe De Perre; Peter Wipf; Cynthia T McMurray; Linda S Lee; Jason R Cannon
Journal:  Toxicol Sci       Date:  2019-12-01       Impact factor: 4.849

7.  Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.

Authors:  Fanpeng Zhao; Wenzhang Wang; Chunyu Wang; Sandra L Siedlak; Hisashi Fujioka; Beisha Tang; Xiongwei Zhu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-16       Impact factor: 5.187

8.  Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Authors:  David K Simon; Nathan Pankratz; Diane K Kissell; Michael W Pauciulo; Cheryl A Halter; Alice Rudolph; Ronald F Pfeiffer; William C Nichols; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2010-04-01       Impact factor: 2.103

9.  Celastrol from 'Thunder God Vine' protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson's disease.

Authors:  Bong-Suk Choi; Hyool Kim; Hyo Jeong Lee; Kumar Sapkota; Se Eun Park; Seung Kim; Sung-Jun Kim
Journal:  Neurochem Res       Date:  2013-11-09       Impact factor: 3.996

10.  Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity.

Authors:  Mubeen A Ansari; Jeffrey N Keller; Stephen W Scheff
Journal:  Free Radic Biol Med       Date:  2008-09-09       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.